HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

Autor: A. Arjona-Sánchez, P. Barrios, E. Boldo-Roda, B. Camps, J. Carrasco-Campos, V. Concepción Martín, A. García-Fadrique, A. Gutiérrez-Calvo, R. Morales, G. Ortega-Pérez, E. Pérez-Viejo, A. Prada-Villaverde, J. Torres-Melero, E. Vicente, P. Villarejo-Campos, J. M. Sánchez-Hidalgo, A. Casado-Adam, Ruben García-Martin, Manuel Medina, T. Caro, C. Villar, Enrique Aranda, M. T. Cano-Osuna, C. Díaz-López, E. Torres-Tordera, F. J. Briceño-Delgado, S. Rufián-Peña

Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)

Abstract Background Local relapse and peritoneal carcinomatosis (PC) for pT4 colon cancer is estimated in 15,6% and 36,7% for 12 months and 36 months from surgical resection respectively, achieving a 5 years overall survival of 6%. There are promisin

Externí odkaz: https://doaj.org/article/764d8fa3c47f408b871b3922e84c7d9b

Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

Autor: L. Gonzalez-Bayon, P. Barrios, Fernando Pereira, R. Morales, J. Torres-Melero, F.C. Muñoz-Casares, José Francisco López Gil, Santiago González-Moreno, Victor Lopez-Lopez, P. Bretcha-Boix, P.A. Cascales-Campos, A Arjona

Publikováno v: Clinical and Translational Oncology. 22:130-136

The attitude toward cytoreductive surgery with HIPEC in peritoneal carcinomatosis from colorectal cancer is unclear. The aim of this study is to report the perioperative outcomes after cytoreductive surgery with HIPEC in patients ≥ 75 years. This r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795a9d378fff5b54e58a4e392161ea03
https://doi.org/10.1007/s12094-019-02124-9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

Autor: Manuel Medina, Ruben García-Martin, A. Prada-Villaverde, P. Villarejo-Campos, T. Caro, Sebastián Rufián-Peña, V. Concepcion Martin, B. Camps, J. Torres-Melero, Enrique Aranda, E. Boldo-Roda, Cesar Diaz-Lopez, E. Pérez-Viejo, Carlos Villar, F.J. Briceño-Delgado, Eva M Torres-Tordera, Álvaro Arjona-Sánchez, E. Vicente, J. Carrasco-Campos, Ángela Casado-Adam, J.M. Sánchez-Hidalgo, G. Ortega-Pérez, A. Gutiérrez-Calvo, P. Barrios, R. Morales, Alfonso García-Fadrique, M. T. Cano-Osuna

Publikováno v: Bmc Cancer
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BMC Cancer

Background: Local relapse and peritoneal carcinomatosis (PC) for pT4 colon cancer is estimated in 15,6% and 36,7% for 12 months and 36 months from surgical resection respectively, achieving a 5 years overall survival of 6%. There are promising result

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bde9757631cd771a7ef82e08ff20c766
https://doi.org/10.1186/s12885-018-4096-0

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.